FDA Inspection 750125 — Aurobindo Pharma Ltd

Aurobindo Pharma Ltd — FEI 3004021229

The FDA completed an inspection of Aurobindo Pharma Ltd on September 8, 2011 in Medchal. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 8, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Medchal (India)

Citations

IDCFRDescription
890621 CFR 314.81(b)(1)(i)Mix-up